Transcriptome analysis of high-grade urothelial carcinomas revealed that CXCL16 expression is significantly associated with PD-L1-mediated immune evasion, indicating its role in promoting tumor immune tolerance and progression [134,172]. Here, CXCL16 is linked to neoplasm.